Respiratory syncytial virus infection in patients with cancer: still more questions than answers.

and ejection fraction were recovered during tigecycline and levosimendan therapy. It is also of note that, despite the recently described evolution of resistance of MDR gram-negative organisms to tigecycline [1], the tigecycline MIC remained unchanged in all K. pneumoniae isolates during the management of our mediastinitis case. These data may prove to be essential for managing serious MDR infections that require prolonged courses of antimicrobial therapy.